Mechanisms of Resistance to EGFR TKI and New Treatment Strategies

Mechanisms of Resistance to EGFR TKI and New Treatment Strategies

CRSF 07th Masterclass: Mechanism of Resistance to Osimertinib in EGFR Mutated Lung Cancer|Dr. MandalПодробнее

CRSF 07th Masterclass: Mechanism of Resistance to Osimertinib in EGFR Mutated Lung Cancer|Dr. Mandal

15 Years of Advances in EGFR Mutant Lung CancerПодробнее

15 Years of Advances in EGFR Mutant Lung Cancer

Time for Even More Precision in Testing and Treatment of EGFR-Mutated NSCLCПодробнее

Time for Even More Precision in Testing and Treatment of EGFR-Mutated NSCLC

Raffaele Califano, ESMO 2018 – Mechanisms of resistance in non-small cell lung cancerПодробнее

Raffaele Califano, ESMO 2018 – Mechanisms of resistance in non-small cell lung cancer

2023 Best of Lung: Targeted Therapies in Lung CancerПодробнее

2023 Best of Lung: Targeted Therapies in Lung Cancer

Heterogeneity of NSCLC and precipitating oncogenic driver mutationsПодробнее

Heterogeneity of NSCLC and precipitating oncogenic driver mutations

ALK Positive Lung Cancer in 2023 and Beyond: Thinking Outside the Box with Dr. Alice ShawПодробнее

ALK Positive Lung Cancer in 2023 and Beyond: Thinking Outside the Box with Dr. Alice Shaw

TKI Resistance: More than just Abl mutationsПодробнее

TKI Resistance: More than just Abl mutations

Future Research and Treatment Options | 2023 Living with EGFR-Mutant Lung Cancer Patient ForumПодробнее

Future Research and Treatment Options | 2023 Living with EGFR-Mutant Lung Cancer Patient Forum

2017 Summer Symposium: Franziska MichorПодробнее

2017 Summer Symposium: Franziska Michor

Novel therapy for Lung Cancer: From targeted therapy to immuno-therapy and back again!Подробнее

Novel therapy for Lung Cancer: From targeted therapy to immuno-therapy and back again!

Dr. Scagliotti on Mechanisms of Resistance to EGFR TKIsПодробнее

Dr. Scagliotti on Mechanisms of Resistance to EGFR TKIs

Acquired EGFR resistance: What are the current therapeutic strategies?Подробнее

Acquired EGFR resistance: What are the current therapeutic strategies?

TKI-resistant EGFR-mutant NSCLCПодробнее

TKI-resistant EGFR-mutant NSCLC

EGFR mutation positive tumors: Treatment strategies in front line and at relapseПодробнее

EGFR mutation positive tumors: Treatment strategies in front line and at relapse

Mechanisms of TKI resistanceПодробнее

Mechanisms of TKI resistance

Biopsy Methods, 3rd Generation EGFR TKIs, and the Future of Mutation TestingПодробнее

Biopsy Methods, 3rd Generation EGFR TKIs, and the Future of Mutation Testing